You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP007/#1383  A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)

Article metrics

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS04. Endometrial/Uterine corpus cancers
TP007/#1383  A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 202385021
Dec 202355011
Jan 20242903
Feb 20243202
Mar 202432011
Apr 20242001
May 20242003
Jun 20241403
Jul 20243203
Aug 2024704
Sep 20243603
Oct 2024601
Total368066